Literature DB >> 27793965

Sporadic and Infectious Human Prion Diseases.

Robert G Will1, James W Ironside1.   

Abstract

Human prion diseases are rare neurodegenerative diseases that have become the subject of public and scientific interest because of concerns about interspecies transmission and the unusual biological properties of the causal agents: prions. These diseases are unique in that they occur in sporadic, hereditary, and infectious forms that are characterized by an extended incubation period between exposure to infection and the development of clinical illness. Silent infection can be present in peripheral tissues during the incubation period, which poses a challenge to public health, especially because prions are relatively resistant to standard decontamination procedures. Despite intense research efforts, no effective treatment has been developed for human prion diseases, which remain uniformly fatal.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27793965      PMCID: PMC5204333          DOI: 10.1101/cshperspect.a024364

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  88 in total

1.  Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom.

Authors:  A J Valleron; P Y Boelle; R Will; J Y Cesbron
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

2.  Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues.

Authors:  M E Bruce; I McConnell; R G Will; J W Ironside
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

3.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

4.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.

Authors:  M R Scott; R Will; J Ironside; H O Nguyen; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

Authors:  P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

Review 6.  Iatrogenic Creutzfeldt-Jakob disease at the millennium.

Authors:  P Brown; M Preece; J P Brandel; T Sato; L McShane; I Zerr; A Fletcher; R G Will; M Pocchiari; N R Cashman; J H d'Aignaux; L Cervenáková; J Fradkin; L B Schonberger; S J Collins
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

7.  Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.

Authors:  A J Green; E J Thompson; G E Stewart; M Zeidler; J M McKenzie; M A MacLeod; J W Ironside; R G Will; R S Knight
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

8.  Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK.

Authors:  Jean-Philippe Brandel; Michael Preece; Paul Brown; Esther Croes; Jean-Louis Laplanche; Yves Agid; Robert Will; Annick Alpérovitch
Journal:  Lancet       Date:  2003-07-12       Impact factor: 79.321

9.  Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis.

Authors:  Pierre-yves Boëlle; Guy Thomas; Alain-Jacques Valleron; Jean-Yves Cesbron; Robert Will
Journal:  Stat Methods Med Res       Date:  2003-06       Impact factor: 3.021

10.  UK dietary exposure to BSE in beef mechanically recovered meat: by birth cohort and gender.

Authors:  J D Cooper; S M Bird
Journal:  J Cancer Epidemiol Prev       Date:  2002
View more
  17 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Detection of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease Patients Using a New Automated Capillary Western Assay.

Authors:  A Fourier; A Dorey; A Perret-Liaudet; I Quadrio
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

Review 3.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

4.  A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of Two Prion Strains in Highly Susceptible Transgenic Mouse Models.

Authors:  Alicia Otero; Carlos Hedman; Natalia Fernández-Borges; Hasier Eraña; Belén Marín; Marta Monzón; Manuel A Sánchez-Martín; Romolo Nonno; Juan José Badiola; Rosa Bolea; Joaquín Castilla
Journal:  Mol Neurobiol       Date:  2019-03-07       Impact factor: 5.590

5.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

6.  S. pombe placed on the prion map.

Authors:  Jacqueline Hayles
Journal:  Microb Cell       Date:  2017-02-03

7.  Transmission of Cerebral β-Amyloidosis Among Individuals.

Authors:  Tsuyoshi Hamaguchi; Kenjiro Ono; Masahito Yamada
Journal:  Neurochem Res       Date:  2022-03-11       Impact factor: 4.414

Review 8.  Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.

Authors:  Jorge M Charco; Hasier Eraña; Vanessa Venegas; Sandra García-Martínez; Rafael López-Moreno; Ezequiel González-Miranda; Miguel Ángel Pérez-Castro; Joaquín Castilla
Journal:  Pathogens       Date:  2017-12-14

Review 9.  Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases.

Authors:  Hasier Eraña; Jorge M Charco; Ezequiel González-Miranda; Sandra García-Martínez; Rafael López-Moreno; Miguel A Pérez-Castro; Carlos M Díaz-Domínguez; Adrián García-Salvador; Joaquín Castilla
Journal:  Biomolecules       Date:  2020-03-19

10.  Autoantibodies against the prion protein in individuals with PRNP mutations.

Authors:  Karl Frontzek; Manfredi Carta; Marco Losa; Mirka Epskamp; Georg Meisl; Alice Anane; Jean-Philippe Brandel; Ulrike Camenisch; Joaquín Castilla; Stéphane Haïk; Tuomas Knowles; Ewald Lindner; Andreas Lutterotti; Eric Vallabh Minikel; Ignazio Roiter; Jiri G Safar; Raquel Sanchez-Valle; Dana Žáková; Simone Hornemann; Adriano Aguzzi
Journal:  Neurology       Date:  2020-02-25       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.